End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,867 CLP | +0.27% | +1.21% | +12.83% |
May. 03 | Cencosud S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Cencosud S.A. Announces Election of New Board Members | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Its low valuation, with P/E ratio at 9.33 and 8.52 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The stock, which is currently worth 2024 to 0.6 times its sales, is clearly overvalued in comparison with peers.
- This company will be of major interest to investors in search of a high dividend stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Retail & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.83% | 5.81B | B | ||
-12.22% | 37.91B | A- | ||
+9.60% | 35.52B | C | ||
+8.71% | 33.68B | A | ||
-0.06% | 18.5B | B | ||
+1.80% | 14.51B | B | ||
-11.20% | 14.1B | B- | ||
+22.49% | 12.7B | B- | ||
-8.33% | 12.27B | B+ | ||
-.--% | 11.82B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CENCOSUD Stock
- Ratings Cencosud S.A.